Anavex Life Sciences Corp. (AVXL)
4.65
-0.11
(-2.31%)
USD |
NASDAQ |
Mar 06, 16:00
4.655
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences Total Assets (Quarterly) : 132.99M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Nephros, Inc. | 13.25M |
| Becton, Dickinson & Co. | 54.84B |
| Cabaletta Bio, Inc. | 189.76M |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.371M |
| Shareholders Equity (Quarterly) | 126.62M |
| Current Ratio | 20.87 |